GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The hormone progesterone is readily converted to 3alpha-OH-5alpha-pregnan-20-one (3alpha,5alpha-THP) in the brains of males and females. In the brain, 3alpha,5alpha-THP acts like a sedative, decreasing anxiety and reducing seizure activity, by enhancing the function of GABA (gamma-aminobutyric acid), the brain's major inhibitory neurotransmitter. Symptoms of premenstrual syndrome (PMS), such as anxiety and seizure susceptibility, are associated with sharp declines in circulating levels of progesterone and, consequently, of levels of 3alpha,5alpha-THP in the brain. Abrupt discontinuation of use of sedatives such as benzodiazepines and ethanol can also produce PMS-like withdrawal symptoms. Here we report a progesterone-withdrawal paradigm, designed to mimic PMS and post-partum syndrome in a rat model. In this model, withdrawal of progesterone leads to increased seizure susceptibility and insensitivity to benzodiazepine sedatives through an effect on gene transcription. Specifically, this effect was due to reduced levels of 3alpha,5alpha-THP which enhance transcription of the gene encoding the alpha4 subunit of the GABA(A) receptor. We also find that increased susceptibility to seizure after progesferone withdrawal is due to a sixfold decrease in the decay time for GABA currents and consequent decreased inhibitory function. Blockade of the alpha4 gene transcript prevents these withdrawal properties. PMS symptoms may therefore be attributable, in part, to alterations in expressio…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This effect involves a 6-fold decrease in the GABAA current time constant.”
From Fibromyalgia pathogenesis explained by a neuroendocrine multistable model (2024) · cites this paper as [55]
In the citing paper
“In a progesterone-withdrawal paradigm in the rat, mimicking post-menstrual and post-partum syndromes, reduced levels of allopregnanolone enhance the expression of GABAA α4 subunit, involving GABAA reduced activity [55].”
From Fibromyalgia pathogenesis explained by a neuroendocrine multistable model (2024) · cites this paper as [55]
Citations
Cites
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225 · cited 1×
“, decreasing anxiety and reducing seizure activity, by enhancing the function of GABA (γ-aminobutyric acid”
BackgroundPurdy, R. H., Morrow, A. L., Moore, P. H., & Paul, S. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4553 · Cited by 951
Bitran, D., Hilvers, R. J., & Kellogg, C. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90761-j · Cited by 457
Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one
Belelli, D., Bolger, M. B., & Gee, K. W. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90077-0 · Cited by 323
Wafford, K. A., Thompson, S. A., Thomas, D., Sikela, J., Wilcox, A. S., & Whiting, P. J. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09339-3 · Cited by 268
Devaud, L. L., Fritschy, J., Sieghart, W., & Morrow, A. L. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010126.x · Cited by 261
Cloning, pharmacological characteristics and expression pattern of the rat GABAA receptor α4 subunit
Wisden, W., Herb, A., Wieland, H., Keinänen, K., Lüddens, H., & Seeburg, P. H. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81076-k · Cited by 260
Twyman, R. E., & Macdonald, R. L. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019334 · Cited by 243
Bäckström, T., Zetterlund, B., Blom, S., & Romano, M. (1984) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb07807.x · Cited by 242
The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABAA receptors
Brot, M. D., Akwa, Y., Purdy, R. H., Koob, G. F., & Britton, K. T. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00096-4 · Cited by 234
Research works printed but not linked: 1
- Wafford, K. A. et al. Functional characterization of human GABA receptors containing the α4 subunit. Mol. Pharmacol. 50, 670–678 (1996).
Cited by
Items 101–200 of 561
Role of neurosteroids in catamenial epilepsy
Reddy, D. S. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2004.09.003 · Cited by 149
Reddy, D. S. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.002 · Cited by 148
Herzog, A. G. (2015) · Seizure · doi:10.1016/j.seizure.2015.02.024 · Cited by 153
Neurosteroid Replacement Therapy for Catamenial Epilepsy
Reddy, D. S., & Rogawski, M. A. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.01.006 · Cited by 144
“Abrupt discontinuation of progesterone after chronic treatment for 3 weeks leads to proconvulsant effects.(58) This can be considered a rudimentary model of catamenial epilepsy.”
Hsu, F.-C., Zhang, G.-J., Raol, Y. S. H., Valentino, R. J., Coulter, D. A., & Brooks-Kayal, A. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2131679100 · Cited by 144
Self-citationPathogenesis in Menstrual Cycle‐Linked CNS Disorders
BÄCKSTRÖM, T., ANDERSSON, A., ANDREÉ, L., BIRZNIECE, V., BIXO, M., BJÖRN, I., HAAGE, D., ISAKSSON, M., JOHANSSON, I., LINDBLAD, C., et al. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1286.005 · Cited by 143
Neurosteroid Modulation of GABA IPSCs Is Phosphorylation Dependent
Fáncsik, A., Linn, D. M., & Tasker, J. G. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03067.2000 · Cited by 142
“Variations in subunit subtypes change or eliminate completely the neurosteroids’ ability to modulate GABA currents (Shingai et al., 1991; Zaman et al., 1992; Puia et al., 1993; Zhu et al., 1996; Maitra and Reynolds, 1998, 1999; Smith et al., 1998; Brussaard et al., 1999).”
BackgroundSteroid hormone fluctuations and GABAAR plasticity
Maguire, J., & Mody, I. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.06.019 · Cited by 137
“Progesterone withdrawal has been shown to increase expression of GABA A R a4 and d expression in the hippocampus (Smith et al., 1998) and periaqueductal grey (PAG) (Griffiths and Lovick, 2005a).”
BackgroundMoore, F. L., & Evans, S. J. (1999) · Brain, Behavior and Evolution · doi:10.1159/000006610 · Cited by 135
“Similarly, symptoms of premenstrual syndrome are temporally associated with declines in P4, but are attributed to the actions of a P4 metabolite (3αOH-5α-pregan-20-one) on the GABAA receptor [Smith et al., 1998].”
BackgroundRoberts, D. S., Hu, Y., Lund, I. V., Brooks-Kayal, A. R., & Russek, S. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600167200 · Cited by 135
Excitability Changes Related to GABAAReceptor Plasticity during Pregnancy
Maguire, J., Ferando, I., Simonsen, C., & Mody, I. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2162-09.2009 · Cited by 134
“In addition, several studies reported changes in GABAAR subunit expression in progesterone withdrawal models, mainly an increase in 4 and subunit expression (Smith et al., 1998; Sundstrom-Poromaa et al., 2002).”
BackgroundInfluentialSmith, S. S., Ruderman, Y., Frye, C. A., Homanics, G. E., & Yuan, M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0168-3 · Cited by 146
“This BDZ insensitivity is prevented when α4 expression is suppressed using antisense oligonucleotide administration intraventricularly (Smith et al. 1998a), suggesting that BDZ responsiveness can reflect the levels of α4 expression.”
BackgroundMethodInfluentialSelf-citationAspects of the homeostaic plasticity of GABAA receptor‐mediated inhibition
Mody, I. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.077362 · Cited by 133
“Severe mood disorders that can occur during the menstrual cycle and following pregnancy are suggested to involve alterations in the function of synaptic GABAARs (Majewska, 1992; Olsen & Sapp, 1995; Smith, 2001; Rupprecht, 2003) triggered by rapid decreases in the concentrations of these progesterone-derived neurostero…”
BackgroundInfluentialLocci, A., & Pinna, G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13843 · Cited by 132
“GABAARs containing α4 subunits are overexpressed during progesterone withdrawal (Smith et al., 1998) and after inhibition of 5α-reductase, which decreases brain Allo levels.”
BackgroundFear recognition across the menstrual cycle
Pearson, R., & Lewis, M. B. (2005) · Hormones and Behavior · doi:10.1016/j.yhbeh.2004.11.003 · Cited by 132
“Such an effect would be supported by work conducted by Smith et al. (1998), who demonstrated how progesterone’s metabolite allopregnanolone is active in the hippocampus area.”
Brussaard, A. B., Devay, P., Leyting‐Vermeulen, J. L., & Kits, K. S. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0513v.x · Cited by 131
Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy
Reddy, D. S., & Rogawski, M. A. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.10200.x · Cited by 130
“(26,27) that withdrawal is associated with increased a4subunit expression.”
BackgroundKoksma, J.-J., van Kesteren, R. E., Rosahl, T. W., Zwart, R., Smit, A. B., Lüddens, H., & Brussaard, A. B. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00788.2003 · Cited by 129
“…subunits that mediate neurosteroid effects, no adequate explanation for the apparent correlation between diversity in receptor subtype and neurosteroid sensitivity has been put forward (Belelli et al., 1996; Zhu et al., 1996; Brussaard et al., 1997; Davies et al., 1997; Smith et al., 1998a,b).”
BackgroundInfluentialGABA receptors, progesterone and premenstrual dysphoric disorder
Poromaa, I. S., Smith, S. S., & Gulinello, M. E. (2003) · Archives of Women s Mental Health · doi:10.1007/s00737-002-0147-1 · Cited by 142
“…to the sedative and anxiolytic effects of GABAergic modulators (Biggio et al., 2001; Follesa et al., 2001; Follesa et al., 2000; Friedman et al., 1993; Gulinello et al., 2002; Gulinello et al., 2001; Smith et al., 1998a; Smith et al., 1998b; Smith, 2002; Yu et al., 1996a; Yu et al., 1996b).”
BackgroundResultInfluentialSelf-citationSanna, E., Mostallino, M. C., Busonero, F., Talani, G., Tranquilli, S., Mameli, M., Spiga, S., Follesa, P., & Biggio, G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-37-11711.2003 · Cited by 139
“…of the ␣4 subunit associated with withdrawal from ethanol (Devaud et al., 1995, 1997; Mahmoudi et al., 1997; Matthews et al., 1998; Cagetti et al., 2003; Follesa et al., 2003 ) as well as other positive allosteric modulators of the GABA A receptors (Smith et al., 1998b; Follesa et al., 2000).”
Follesa, P., Serra, M., Cagetti, E., Pisu, M. G., Porta, S., Floris, S., Massa, F., Sanna, E., & Biggio, G. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23238-7 · Cited by 128
“…in the abundance of the a4 subunit mRNA during withdrawal from progesterone in the rat pseudopregnancy model is associated with changes in the kinetics of hippocampal GABAA receptor-mediated currents, with experimental anxiety, and with increased seizure susceptibility (Smith et al., 1998b).”
InfluentialIs there a physiological role for the neurosteroid THDOC in stress-sensitive conditions?
Reddy, D. S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00023-3 · Cited by 121
Ladurelle, N., Eychenne, B., Denton, D. A., Blair-West, J. R., Schumacher, M., Röbel, P., & Baulieu, É.-É. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01953-3 · Cited by 124
Epperson, C. N., O’Malley, S. S., Czarkowski, K. A., Gueorguieva, R. V., Jatlow, P. I., Sanacora, G., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.09.021 · Cited by 132
“Chronic exposure to ALLO results in downregulation and desensitization of the GABAA receptor (Smith et al 1998).”
BackgroundSteiger, J. L., & Russek, S. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.12.002 · Cited by 136
Gonadal Steroids in the Treatment of Mood Disorders
Epperson, C. N., Wisner, K. L., & Yamamoto, B. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199909000-00010 · Cited by 120
Numan, M., Roach, J. K., del Cerro, M. C. R., Guillamón, A., Segovia, S., Sheehan, T. P., & Numan, M. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01424-9 · Cited by 125
Pineles, S. L., Nillni, Y. I., King, M. W., Patton, S. C., Bauer, M. R., Mostoufi, S. M., Gerber, M. R., Hauger, R., Resick, P. A., Rasmusson, A. M., et al. (2016) · Journal of Abnormal Psychology · doi:10.1037/abn0000138 · Cited by 117
Matsumoto, K., Puia, G., Dong, E., & Pinna, G. (2007) · Stress · doi:10.1080/10253890701200997 · Cited by 117
“…a4 subunits is low in the brain, except in some regions such as the thalamus and dentate gyrus, enhanced expression of this GABAA-R subtype is observed in animal models of premenstrual syndrome (Smith et al. 1998a), epilepsy (Banerjee et al. 1998) and alcohol withdrawal (Cagetti et al. 2003).”
BackgroundGulinello, M. E., & Smith, S. S. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045120 · Cited by 125
“Furthermore, previous studies indicate that inhibition of neurosteroid synthesis during progesterone exposure prevents the up-regulation of the GABAA receptor 4 subunit and changes in anxiety levels (Smith et al., 1998a,b; Follesa et al., 2000; Frye et al., 2000).”
BackgroundMethodInfluentialSelf-citationRoberts, D. S., Raol, Y. H., Bandyopadhyay, S., Lund, I. V., Budreck, E. C., Passini, M. J., Wolfe, J. H., Brooks-Kayal, A. R., & Russek, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501434102 · Cited by 114
Deligiannidis, K. M., Kroll-Desrosiers, A. R., Mo, S., Nguyen, H. P., Svenson, A., Jaitly, N., Hall, J. E., Barton, B. A., Rothschild, A. J., & Shaffer, S. A. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.05.010 · Cited by 114
Gulinello, M., Orman, R., & Smith, S. S. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02479.x · Cited by 112
“Western blot a4 levels were measured in amygdala crude membrane fractions using Western blot procedures explained in detail elsewhere (Smith et al., 1998b).”
BackgroundMethodResultInfluentialSelf-citationRudick, C. N., Gibbs, R. B., & Woolley, C. S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04479.2003 · Cited by 112
“For example, regulation of the ␣1 and ␣2 (Hollrigel and Soltesz, 1997; Lavoie et al., 1997) or ␣4 (Smith et al., 1998) GABA A receptor subunits has been shown to alter IPSC decay time.”
Crowley, S. K., & Girdler, S. S. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3572-8 · Cited by 111
“In animals, flumazenil changes its actions from a GABAAR antagonist (or inert compound) to a GABAAR agonist, but only in the presence of a conformational change in the GABAAR (Gangisetty and Reddy 2010; Smith et al. 1998).”
Cellular and molecular effects of steroid hormones on CNS excitability.
Smith, S. S., & Woolley, C. S. (2004) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.71.suppl_2.s4 · Cited by 123
“First, suppression of α4 expression using antisense technology prevents the increase in seizure susceptibility observed following progesterone withdrawal.(30) Under conditions of suppressed α4 expression, measures of reduced inhibition seen at the circuit and synaptic level following progesterone withdrawal are also p…”
BackgroundSelf-citationAllopregnanolone as a mediator of affective switching in reproductive mood disorders
Schiller, C. E., Schmidt, P. J., & Rubinow, D. R. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3599-x · Cited by 109
“Second, progesterone withdrawal in rats produces anxiety and insensitivity to benzodiazepines due to withdrawal of ALLO, with consequent induction of GABAA α4-subunit levels and inhibition of GABA currents (Smith et al. 1998a; Smith et al. 1998b).”
Female reproductive steroids and neuronal excitability
Finocchi, C., & Ferrari, M. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0532-5 · Cited by 109
Premenstrual dysphoric disorder and psychiatric co-morbidity
Kim, D. R., Gyulai, L., Freeman, E. W., Morrison, M. F., Baldassano, C. F., & Dub�, B. (2004) · Archives of Women s Mental Health · doi:10.1007/s00737-003-0027-3 · Cited by 114
Pineles, S. L., Nillni, Y. I., Pinna, G., Irvine, J., Webb, A., Arditte Hall, K. A., Hauger, R., Miller, M. W., Resick, P. A., Orr, S. P., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.04.024 · Cited by 106
Cooper, E. J., Johnston, G. A. R., & Edwards, F. A. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.00437.x · Cited by 106
“9822 Keywords: Bicikova et al. 1998), can cause fluctuation in mood and changes in stress-like tension (Dennerstein et al. 1985; Smith et al. 1998).”
BackgroundMurphy, S. J., Littleton‐Kearney, M. T., & Hurn, P. D. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000037990.07114.07 · Cited by 104
“We speculated that the increased striatal injury we observed (Murphy et al., 2000) could be due to GABA current modulation and alterations in GABAA receptor 4 subunit levels as a result of sharply declining plasma progesterone levels (Moran and Smith, 1998; Smith et al., 1998) after ischemia.”
BackgroundEngel, S. R., & Grant, K. A. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)46067-3 · Cited by 112
Gulinello, M. E., Gong, Q. H., & Smith, S. S. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00171-5 · Cited by 120
“PWD clearly results in faster decay times and decreases the total GABA-gated current in isolated hippocampal CA1 neurons (Smith et al., 1998b), an effect which is prevented by the administration of anti-sense oligonucleotides that prevent α4 subunit up-regulation.”
BackgroundMethodResultInfluentialSelf-citationInflammatory Pain Upregulates Spinal Inhibition via Endogenous Neurosteroid Production
Poisbeau, P., Patte-Mensah, C., Keller, A. F., Barrot, M., Breton, J.-D., Luis-Delgado, O. E., Freund-Mercier, M. J., Mensah-Nyagan, A. G., & Schlichter, R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3841-05.2005 · Cited by 104
“…sensitivity to neurosteroids is highly variable as a function of developmental stage (Poisbeau et al., 1997; Cooper et al., 1999), physiological (Smith et al., 1998; Koksma et al., 2003) or pathological (Mtchedlishvili et al., 2001; Leroy et al., 2004) states, as well as subunit composition, or…”
BackgroundCagetti, E., Pinna, G., Guidotti, A., Baicy, K., & Olsen, R. W. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.10.001 · Cited by 107
Follesa, P., Porcu, P., Sogliano, C., Cinus, M., Biggio, F., Mancuso, L., Mostallino, M. C., Paoletti, A. M., Purdy, R. H., Biggio, G., et al. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00187-3 · Cited by 114
Progesterone Exacerbates Striatal Stroke Injury in Progesterone-Deficient Female Animals
Murphy, S. J., Traystman, R. J., & Hurn, P. D. (2000) · Stroke · doi:10.1161/01.str.31.5.1173 · Cited by 102
The GABA-A receptor gene family: new targets for therapeutic intervention
Whiting, P. J. (1999) · Neurochemistry International · doi:10.1016/s0197-0186(99)00048-0 · Cited by 115
Diversity of ovarian steroid signaling in the hypothalamus
Rønnekleiv, O. K., & Kelly, M. J. (2005) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2005.05.001 · Cited by 107
Endogenous and synthetic neurosteroids in treatment of Niemann–Pick Type C disease
Mellon, S. H., Gong, W., & Schonemann, M. D. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.05.012 · Cited by 108
Update on the Neurobiology of Alcohol Withdrawal Seizures
Rogawski, M. A. (2005) · Epilepsy Currents · doi:10.1111/j.1535-7511.2005.00071.x · Cited by 100
“in animals with increased α4-subunit expression (50,51).”
Foldvary-Schaefer, N., & Falcone, T. (2003) · Neurology · doi:10.1212/wnl.61.6_suppl_2.s2 · Cited by 104
Brussaard, A. B., & Herbison, A. E. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01540-4 · Cited by 105
Kumar, S., Kralic, J. E., O’Buckley, T. K., Grobin, A. C., & Morrow, A. L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01894.x · Cited by 106
Frye, C. A., & Bayon, L. E. (1998) · Neuroendocrinology · doi:10.1159/000054375 · Cited by 98
“Although previous studies have examined seizures and progestin concentrations in some hormonal states, the present study is the first to link central 3α,5α-THP in multiple endogenous endocrine states characterized by different absolute and relative concentrations of progestins. Interestingly, the greatest seizure dura…”
ResultTolerance to allopregnanolone with focus on the GABA‐A receptor
Turkmen, S., Backstrom, T., Wahlstrom, G., Andreen, L., & Johansson, I. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01059.x · Cited by 97
“The changes in the hippocampus seem to be related to up-regulation of the a4 subunit (Smith et al., 1998a,b).”
BackgroundProgesterone withdrawal I: pro-convulsant effects
Moran, M. H., & Smith, S. S. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00782-3 · Cited by 98
Self-citationNeurosteroids, GABAA receptors, and ethanol dependence
Follesa, P., Biggio, F., Talani, G., Murru, L., Serra, M., Sanna, E., & Biggio, G. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0126-0 · Cited by 102
“…expression is also induced by withdrawal of benzodiazepine receptor ligands (Follesa et al. 2001, 2002) or of neurosteroids (Follesa et al. 2000; Smith et al. 1998b), suggesting that it might play an important role in the cellular hyperexcitability and anxiety-like behavior apparent in both…”
BackgroundWu, X. Y., Gangisetty, O., Carver, C. M., & Reddy, D. S. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.203653 · Cited by 103
“Although some studies show that progesterone and its metabolites regulate GABAARs to affect seizure susceptibility, they are limited to exogenous application of progesterone or studying a few subunits (Smith et al., 1998a,b; Maguire et al., 2005).”
BackgroundResultWidespread expression of GABAA receptor subunits in peripheral tissues
Akinci, M., & Schofield, P. R. (1999) · Neuroscience Research · doi:10.1016/s0168-0102(99)00078-4 · Cited by 111
Lovick, T. A. (2000) · The Neuroscientist · doi:10.1177/107385840000600113 · Cited by 91
Molecular Characterization of a First Human 3(α→β)-Hydroxysteroid Epimerase
Huang, X.-F., & Luu-The, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000562200 · Cited by 89
Higaki, Y., Usami, N., Shintani, S., Ishikura, S., El-Kabbani, O., & Hara, A. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00206-5 · Cited by 89
Khisti, R. T., & Chopde, C. T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02373-8 · Cited by 87
Kang, M., Spigelman, I., & Olsen, R. W. (1998) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb05930.x · Cited by 89
The 5-HT 1A receptor knockout mouse and anxiety
Olivier, B., Pattij, T., Wood, S. J., Oosting, R., Sarnyai, Z., & Toth, M. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200111000-00004 · Cited by 89
Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome
SMITH, M. J., Adams, L. F., Schmidt, P. J., Rubinow, D. R., & Wassermann, E. M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01924-8 · Cited by 88
GABAergic systems in the vestibular nucleus and their contribution to vestibular compensation
Gliddon, C. M., DARLINGTON, C., & Smith, P. R. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.11.001 · Cited by 94
Smith, S. S. (2002) · Steroids · doi:10.1016/s0039-128x(01)00170-2 · Cited by 98
Self-citationSanna, E., Mostallino, M. C., Murru, L., Carta, M., Talani, G., Zucca, S., Mura, M. L., Maciocco, E., & Biggio, G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3684-08.2009 · Cited by 88
“…in brain and plasma concentrations of 3 ,5 -THP play an important role in regulation of GABAA-R plasticity and function (Brussaard et al., 1997; Smith et al., 1998a,b; Biggio et al.,. 2006; Mostallino et al., 2006) as well as in development of the GABAergic system in the prefrontal cortex…”
BackgroundResultDevaud, L. L., & Chadda, R. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02176.x · Cited by 87
Region‐ and Sex‐Specific Modulation of Anxiety Behaviours in the Rat
Toufexis, D. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01552.x · Cited by 87
Sun, C., Mtchedlishvili, Z., Erişir, A., & Kapur, J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4141-07.2007 · Cited by 91
“Progesterone treatment and withdrawal caused the increased expres- sion of the 4 subunit in the hippocampus, which is associated with diminished neurosteroid sensitivity of whole-cell GABAA receptor currents (Smith et al., 1998a,b).”
BackgroundMethodInfluentialAndréen, L., Poromaa, I. S., Bixo, M., Nyberg, S., & Bäckström, T. C. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0417-0 · Cited by 92
“Tolerance development has been described earlier as a result of prolonged exposure to GABA-agonists, as in cases of endogenous rise in allopregnanolone concentration during stress, pregnancy, and exogenous treatment with progestagens (Czlonkowska et al. 2001; Palmer et al. 2002; Smith et al. 1998; Turkmen et al. 2006;…”
BackgroundProgesterone neuroprotection: The background of clinical trial failure
Schumacher, M., Denier, C., Oudinet, J., Adams, D., & Guennoun, R. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.11.010 · Cited by 98
Estradiol Facilitates the Release of Neuropeptide Y to Suppress Hippocampus-Dependent Seizures
Ledoux, V. A., Smejkalova, T., May, R. M., Cooke, B. M., & Woolley, C. S. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4688-08.2009 · Cited by 85
“Animal studies consistently support anticonvulsant effects of progesterone, primarily through GABAA receptor modulation (Smith et al., 1998; Kaminski et al., 2004).”
BackgroundLeroy, C., Poisbeau, P., Keller, A. F., & Nehlig, A. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2003.059246 · Cited by 85
“Neurosteroids affect GABAA receptors containing most subunits, except those comprising the α4 subunit (Smith et al. 1998a,b).”
BackgroundGangisetty, O., & Reddy, D. S. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.07.037 · Cited by 84
Social isolation stress and neuroactive steroids
Serra, M., Sanna, E., Mostallino, M. C., & Biggio, G. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.03.004 · Cited by 92
Follesa, P., Concas, A., Porcu, P., Sanna, E., Serra, M., Mostallino, M. C., Purdy, R. H., & Biggio, G. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00125-4 · Cited by 88
Griffiths, J., & Lovick, T. (2005) · Journal of Comparative Neurology · doi:10.1002/cne.20540 · Cited by 81
“We focused initially on 4 and subunits since plasticity of these subunits has been reported in other brain regions in relation to fluctuating gonadal steroid hormone levels (Moran et al., 1998; Smith et al., 1998a,b; Gulinello et al., 2002).”
BackgroundMethodInfluentialStress, ethanol, and neuroactive steroids
Biggio, G., Concas, A., Follesa, P., Sanna, E., & Serra, M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.04.005 · Cited by 96
“Consistent with this notion, depletion of the α4 subunit with the use of antisense RNA prevented the development of withdrawal symptoms in a rat progesterone withdrawal paradigm (Smith et al., 1998a).”
BackgroundInfluentialLi, Y., Pehrson, A. L., Budac, D. P., Sánchez, C., & Gulinello, M. E. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.06.034 · Cited by 90
Luteinizing hormone-releasing hormone (LHRH) neurons: Mechanism of pulsatile LHRH release
Terasawa, E. (2001) · Vitamins and hormones · doi:10.1016/s0083-6729(01)63004-8 · Cited by 91
Metabolic conversion as a pre‐receptor control mechanism for lipophilic hormones
Nobel, S., Abrahmsen, L., & Oppermann, U. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02359.x · Cited by 80
Imidazenil and diazepam increase locomotor activity in mice exposed to protracted social isolation
Pinna, G., Agis-Balboa, R. C., Zhubi, A., Matsumoto, K., Grayson, D. R., Costa, E., & Guidotti, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600329103 · Cited by 79
Papadeas, S., Grobin, A. C., & Morrow, A. L. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02347.x · Cited by 79
Neuroendocrine aspects of catamenial epilepsy
Reddy, D. S. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.04.016 · Cited by 87
“The exogenous P model There are models in which P was administered for extended periods using silastic implants or multiple daily injections (Costa et al., 1995; Smith et al., 1998; Moran and Smith, 1998).”
BackgroundVigabatrin for tuberous sclerosis complex
Curatolo, P., Verdecchia, M., & Bombardieri, R. (2001) · Brain and Development · doi:10.1016/s0387-7604(01)00290-x · Cited by 79
Grobin, A. C., Heenan, E. J., Lieberman, J. A., & Morrow, A. L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01832.2003 · Cited by 75
“Moreover, withdrawal from progesterone metabolites results in functional and structural changes in GABAA receptors (Smith et al., 1998a,b).”
BackgroundAnton, R. F., Myrick, H., Baros, A. M., Latham, P. K., Randall, P. K., Wright, T. M., Stewart, S. H., Waid, R., & Malcolm, R. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181aba6a4 · Cited by 75
Estrous cycle and stress: influence of progesterone on the female brain
Lovick, T. A. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500044 · Cited by 74
Progesterone Prevents Estradiol-Induced Dendritic Spine Formation in Cultured Hippocampal Neurons
Murphy, D. D., & Segal, M. (2000) · Neuroendocrinology · doi:10.1159/000054580 · Cited by 75
Reddy, D. S. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.016 · Cited by 77
Porcu, P., Mostallino, M. C., Sogliano, C., Santoru, F., Berretti, R., & Concas, A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.05.011 · Cited by 77
The cerebellum and neuropsychiatric disorders
Villanueva, R. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.02.023 · Cited by 85
“It has been proposed that the genesis of premenstrual syndrome and postpartum depression might be due, at least in part, to fluctuations in the plasma and brain levels of progresterone neuroactive metabolites able to modulate GABAergic neurotransmission (Smith et al., 1998; Stell et al., 2003).”
BackgroundSchüle, C., Romeo, E., Uzunov, D. P., Eser, D., di Michele, F., Baghai, T. C., Pasini, A., Schwarz, M., Kempter, H., & Rupprecht, R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001782 · Cited by 80
Frye, C. A., & Bayon, L. E. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00182-8 · Cited by 73
Progesterone for premenstrual syndrome
Ford, O., Lethaby, A. E., Roberts, H., & Mol, B. W. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003415.pub3 · Cited by 73
Metadata
- Authors
- Smith, S. S., Gong, Q. H., Hsu, F.-C., Markowitz, R. S., ffrench-Mullen, J. M. H., & Li, X.
- Corresponding author
- Smith, Sheryl S.
- ORCID
- Smith, Sheryl S.
- Venue
- Nature
- Published
- 1998-04
- Volume
- 392
- Issue
- 6679
- Pages
- 926-929
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1647312149
- Semantic Scholar
- 3539e8269bee3fd116e338cc540f9de8e78942b1
- Cited by
- 564
- References
- 31
- Citations by year
- 2026: 1 · 2024: 6 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 6 · 2019: 8 · 2018: 3 · 2017: 7 · 2016: 16 · 2015: 14 · 2014: 16 · 2013: 21 · 2012: 20
- FWCI
- 17.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- progesterone withdrawal, 3alpha,5alpha-THP, premenstrual syndrome, seizure susceptibility, GABA currents, gene transcription, steroid hormones, anxiety, GABAergic inhibition
- MeSH terms
- Animals, Azides, Benzodiazepines, Carbolines, Female, gamma-Aminobutyric Acid, Hippocampus, Indomethacin, Lorazepam, Pregnanolone, Premenstrual Syndrome, Progesterone, Receptors, GABA-A, RNA, Messenger, Anti-Anxiety Agents, Transcription, Genetic, Oligonucleotides, Antisense, Pyramidal Cells, Patch-Clamp Techniques, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.